Allergies represent a significant, rising health concern. Recent figures indicate that 150 million Europeans experience chronic allergic disease…

MINIMUM unit pricing (MUP) was first introduced in Scotland in 2018, raising the price per unit of alcohol to 50p. Now, experts…

BACTERIOPHAGES have been used to successfully treat alcoholic liver disease in mice in a recent study…

I should not be alive to write this. It took a medical miracle, the world’s first ever cure for a virus, and some close timing. It also took me pushing…

PHYSICAL activity could lower the risk of prostate cancer by as much as 51%. For men in the UK, prostate cancer…

ANTHRAX toxin combined with a growth factor has been found to be effective in treating bladder cancer…

The symposium “IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance” took place during the 2019 annual European Academy of Dermatology…

Guselkumab was the first monoclonal antibody targeting the p19 subunit of IL-23 (IL-23p19) to be approved for the treatment of psoriasis.

Prof Augustin opened the symposium by underlining how the management of patients with moderate-to-severe atopic dermatitis (AD) has become more dynamic…